Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer

Cancer Res (2023) 83 (7_Supplement): 3468.

https://doi.org/10.1158/1538-7445.AM2023-3468

Published: 04 April 2023

View article titled, Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer

Journal Articles

Abstract 5185: Intratumoral Escherichia is associated with response to single-agent immune checkpoint inhibition in patients with advanced non-small cell lung cancer

Cancer Res (2023) 83 (7_Supplement): 5185.

https://doi.org/10.1158/1538-7445.AM2023-5185

Published: 04 April 2023

View article titled, Abstract 5185: Intratumoral Escherichia is associated with response to single-agent immune checkpoint inhibition in patients with advanced non-small cell lung cancer

Journal Articles

Abstract 2146: A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response

Michael Rosen, David Amar, Ian Winters, Hira Rizvi, Wensheng Nie, Gregory Wall, Dmitri Petrov, Monte Winslow, Charles Rudin, Joseph Juan

Cancer Res (2022) 82 (12_Supplement): 2146.

https://doi.org/10.1158/1538-7445.AM2022-2146

Published: 15 June 2022

View article titled, Abstract 2146: A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response

Journal Articles

Abstract LB049: Spatial immune determinants of ICB response in STK11-mutated non-small cell lung cancer

Florian Uhlitz, Douglas Linn, Elsa Beyer Krall, Jacklynn Egger, Hira Rizvi, Jason Chang, Benjamin Nicholson, Rami Vanguri, Andrew Chow, Matthew Hellmann, Sohrab Shah

Cancer Res (2022) 82 (12_Supplement): LB049.

https://doi.org/10.1158/1538-7445.AM2022-LB049

Published: 15 June 2022

View article titled, Abstract LB049: Spatial immune determinants of ICB response in STK11-mutated non-small cell lung cancer

Journal Articles

Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma

Chuan Li, Wen-Yang Lin, Hira Rizvi, Hongchen Cai, Christopher D. McFarland, Zoe N. Rogers, Maryam Yousefi, Ian P. Winters, Charles M. Rudin, Dmitri A. Petrov, Monte M. Winslow

Cancer Res (2021) 81 (17): 4570–4580.

https://doi.org/10.1158/0008-5472.CAN-21-0716

Published: 01 September 2021

View article titled, Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma

Includes: Supplementary data

Journal Articles

Abstract 102: Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database

Biagio Ricciuti, Chenguang Wang, Hira Rizvi, Jacklynn Egger, Michele LeNoue-Newton, Marilyn Holt, Shivani Aggarwal, Huakang Tu, Hil Hsu, Xuena Wang, Gataree Ngarmchamnanrith, Victoria Chia, Jocelyn Lee, Robert Scharpf, Valsamo Anagnostou, Christine Lovly, Greg Riely, Mark Awad

Cancer Res (2021) 81 (13_Supplement): 102.

https://doi.org/10.1158/1538-7445.AM2021-102

Published: 01 July 2021

View article titled, Abstract 102: Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database

Journal Articles

Abstract 490: A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC

Cancer Res (2021) 81 (13_Supplement): 490.

https://doi.org/10.1158/1538-7445.AM2021-490

Published: 01 July 2021

View article titled, Abstract 490: A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC

Journal Articles

Abstract 2620: Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates

Samantha Brown, Jessica A. Lavery, Eva M. Lepisto, Caroline McCarthy, Hira Rizvi, Celeste Yu, Kenneth L. Kehl, Shawn M. Sweeney, Julia E. Rudolph, Nikolaus Schultz, Ritika Kundra, Brooke Mastrogiacomo, Phillipe Bedard, Jeremy L. Warner, Gregory J. Riely, Deborah Schrag, Katherine S. Panageas, The AACR Project GENIE Consortium

Cancer Res (2021) 81 (13_Supplement): 2620.

https://doi.org/10.1158/1538-7445.AM2021-2620

Published: 01 July 2021

View article titled, Abstract 2620: Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates

Journal Articles

Abstract 2619: Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data

Jessica A. Lavery, Samantha Brown, Eva Lepisto, Michele L. Lenoue-Newton, Caroline McCarthy, Hira Rizvi, Celeste Yu, Kenneth L. Kehl, Shawn M. Sweeney, Julia E. Rudolph, Nikolaus Schultz, Brooke Mastrogiacomo, Ritika Kundra, Jeremy Warner, Philippe Bedard, Gregory J. Riely, Katherine S. Panageas, Deborah Schrag, AACR Project GENIE Consortium

Cancer Res (2021) 81 (13_Supplement): 2619.

https://doi.org/10.1158/1538-7445.AM2021-2619

Published: 01 July 2021

View article titled, Abstract 2619: Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data

Journal Articles

Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Cancer Res (2020) 80 (16_Supplement): 5666.

https://doi.org/10.1158/1538-7445.AM2020-5666

Published: 15 August 2020

View article titled, Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Journal Articles

Abstract 3210: Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)

Cancer Res (2020) 80 (16_Supplement): 3210.

https://doi.org/10.1158/1538-7445.AM2020-3210

Published: 15 August 2020

View article titled, Abstract 3210: Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)

Journal Articles

Abstract 2514: Inter-test variability in tumor mutational burden (TMB) quantification and identification of TMB thresholds

Natalie Vokes, Elizabeth Jimenez Alguilar, Renato Umeton, Anika Adeni, Lynette Sholl, Matthew Hellmann, Hira Rizvi, Mark Awad, Eliezer Van Allen

Cancer Res (2019) 79 (13_Supplement): 2514.

https://doi.org/10.1158/1538-7445.AM2019-2514

Published: 01 July 2019

View article titled, Abstract 2514: Inter-test variability in tumor mutational burden (TMB) quantification and identification of TMB thresholds

Journal Articles

Abstract 1521: Expression of the tight junctions protein IGSF5 in the colorectal adenoma-carcinoma sequence

Alexandra Briggs, Hira Rizvi, Adelaide M. Carothers, Jiping Wang, Nancy L. Cho, Monica M. Bertagnolli

Cancer Res (2012) 72 (8_Supplement): 1521.

https://doi.org/10.1158/1538-7445.AM2012-1521

Published: 15 April 2012

View article titled, Abstract 1521: Expression of the tight junctions protein IGSF5 in the colorectal adenoma-carcinoma sequence

Journal Articles

Abstract 3304: Hyaluronan mediates interactions between CD44⁺ MSCs and CD34⁺ fibrocytes in Desmoid Tumors.

Hira Rizvi, Adelaide M. Carothers, Monica M. Bertagnolli, Nancy L. Cho

Cancer Res (2012) 72 (8_Supplement): 3304.

https://doi.org/10.1158/1538-7445.AM2012-3304

Published: 15 April 2012

View article titled, Abstract 3304: Hyaluronan mediates interactions between CD44+ MSCs and CD34+ fibrocytes in Desmoid Tumors.

Journal Articles

Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors

Adelaide M. Carothers, Hira Rizvi, Rian M. Hasson, Yvonne I. Heit, Jennifer S. Davids, Monica M. Bertagnolli, Nancy L. Cho

Cancer Res (2012) 72 (1): 346–355.

https://doi.org/10.1158/0008-5472.CAN-11-2819

Published: 02 January 2012

View article titled, Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors

Includes: Supplementary data

Journal Articles

Abstract 2292: Absent E2 liganded AhR inhibits tumor inhibition by ERα in Min mice

Adelaide M. Carothers, Hira Rizvi, Ronald Lubet, Monica Bertagnolli

Cancer Res (2011) 71 (8_Supplement): 2292.

https://doi.org/10.1158/1538-7445.AM2011-2292

Published: 15 April 2011

View article titled, Abstract 2292: Absent E2 liganded AhR inhibits tumor inhibition by ERα in Min mice

Journal Articles

Abstract 484: Persistent activation of mesenchymal stromal cells (MSCs) and tissue repair in the etiology of desmoid tumors (DT)

Adelaide M. Carothers, Hira Rizvi, Yvonne Heit, Rian M. Hasson, Jennifer Davids, Monica M. Bertagnolli, Nancy L. Cho

Cancer Res (2011) 71 (8_Supplement): 484.

https://doi.org/10.1158/1538-7445.AM2011-484

Published: 15 April 2011

View article titled, Abstract 484: Persistent activation of mesenchymal stromal cells (MSCs) and tissue repair in the etiology of desmoid tumors (DT)

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer

Abstract 5185: Intratumoral Escherichia is associated with response to single-agent immune checkpoint inhibition in patients with advanced non-small cell lung cancer

Abstract 2146: A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response

Abstract LB049: Spatial immune determinants of ICB response in STK11-mutated non-small cell lung cancer

Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma

Abstract 102: Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database

Abstract 490: A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC

Abstract 2620: Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates

Abstract 2619: Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data

Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Abstract 3210: Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)

Abstract 2514: Inter-test variability in tumor mutational burden (TMB) quantification and identification of TMB thresholds

Abstract 1521: Expression of the tight junctions protein IGSF5 in the colorectal adenoma-carcinoma sequence

Abstract 3304: Hyaluronan mediates interactions between CD44⁺ MSCs and CD34⁺ fibrocytes in Desmoid Tumors.

Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors

Abstract 2292: Absent E2 liganded AhR inhibits tumor inhibition by ERα in Min mice

Abstract 484: Persistent activation of mesenchymal stromal cells (MSCs) and tissue repair in the etiology of desmoid tumors (DT)

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media